Table 1.
Risk factor tags, attributes, and descriptions
Risk Factor | Indicator | Descriptions |
---|---|---|
Diabetes | Mention | Type 1 or Type 2 diabetes diagnosis, e.g., HXDM. |
High A1c | A1c > 6.5; E.g., A1c: 6.2 | |
High glucose | 2 fasting blood glucose measurements > 126; E.g., SMBP 130. | |
CAD | Mention | Diagnosis or history of CAD. |
Event | E.g., MI, STEMI, NSTEMI, bypass surgery, CABG, percutaneous, cardiac arrest, ischemic cardiomyopathy. | |
Test result | Exercise or pharmacologic stress test showing ischemia, abnormal cardiac catheterization showing coronary stenoses (narrowing) | |
Symptom | Chest pain consistent with angina | |
Hyperlipidemia / Hypercholesterolemia | Mention | Diagnosis/history of Hyperlipidemia or Hypercholesterolemia |
High Cholesterol | Total cholesterol of over 240 | |
High LDL | LDL measurement of over 100 mg/dL | |
Hypertension | Mention | Diagnosis or preexisting condition of Hypertension. |
High BP | BP measurement of over 140/90 mm/hg | |
Obesity | Mention | Description of obesity |
BMI | > 30 | |
Waist | Men >= 40”; woman >= 35” | |
Medications | Diabetes | Metformin, insulin, sulfonylureas, thiazolidinediones, GLP-1 agonists, Meglitinides, DPP-4 inhibitors, Amylin, anti-diabetes medications, combinations. |
CAD | Aspirin, Thienopyridines, beta blockers, ACE inhibitors, nitrates, calcium-channel blockers, combinations. | |
Hyperlipidemia | Statins, fibrates, niacins, ezetimibes, combinations. | |
Hypertension | Beta-blockers, ACE inhibitors ARBs, Thiazide diuretics, calcium-channel blockers, combinations. | |
Obesity | Orlistat (xenical) or Lorqess (Lorcaserin). | |
Family History | Present if the patient has a first-degree relative (parents, siblings, or children) who was diagnosed prematurely (< 55 for male relatives, < 65 for female relatives) with CAD. | |
Smoker | Status: CURRENT, PAST (quit > 1 year ago), EVER (smoked at some point but it is unclear), NEVER (never smoked), or UNKNOWN (not mentioned). |